Forced diuresis and dual-phase 18F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers

Indian Journal of Radiology and Imaging

Volumn 20, Issue 1, 2010, Pages 13-19

  Harkirat, S ^a   Anand, S S ^a   Jacob, M J ^a  

^a ARMY HOSPITAL RESEARCH AND REFERRAL   (India)

Author keywords

Bladder cancer; FDG PET CT; Forced diuresis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FUROSEMIDE;

ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; DIURESIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; URINARY DIVERSION;

EID: 77649146814     PISSN: 09713026     EISSN: 19983808     Source Type: Journal    
DOI: 10.4103/0971-3026.59746     Document Type: Article

References (25)

1. Oehr P, Biersack HJ, Coleman RE (Eds). PET and PET-CT in oncology. first Ed. Heidelberg: Springer-Verlag; 2004. p. 1-364.
2. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42:1S-93.
3. Schöder H, Larson SM, Yeung HW. PET/CT in oncology: Integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med 2004;45:72S-81.
4. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in the evaluation of cancer: Additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200-1209
5. Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, et al. Accuracy of whole-body dual-modality fluorine-18-2-deoxy-Dglucose positron emission tomography and computed tomography (FDG-PET-CT) for tumor staging in solid tumors: Comparison with CT and PET. J Clin Oncol 2004;22:4357-4368
6. Freudenberg LS, Antoch G, Schütt P, Beyer T, Jentzen W, Müller SP, et al. FDG-PET/CT in re-staging of patients with lymphoma. Eur J Nucl Med Mol Imaging 2004;31:325-329
7. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positronemission tomography and computed tomography. N Engl J Med 2003;348:2500-2507 (Pubitemid 36706537)
8. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of 18F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003;44:1797-1803
9. Jadvar H, Parker JA. PET radiotracers. In: Clinical PET and PET/ CT. first ed. London: Springer; 2005. p. 45-67.
10. Kumar R, Zhuang H, Alavi A. PET in the management of urologic malignancies. Radiol Clin North Am 2004;42:1141-1153
11. Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34:274-292
12. Hain SF, Maisey MN. Positron emission tomography for urological tumours. BJU Int 2003;92:159-164
13. Shvarts O, Han KR, Seltzer M, Pantuck AJ, Belldegrun AS. Positron emission tomography in urologic oncology. Cancer Control 2002;9:335-342
14. Kosuda S, Kison PV, Greenough R, Grossman HB, Wahl RL. Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med 1997;24:615-620
15. Ahlström H, Malmström PU, Letocha H, Andersson J, Långström B, Nilsson S. Positron emission tomography in the diagnosis and staging of urinary bladder cancer. Acta Radiol 1996;37:180-185
16. Cook GJR. Artifacts and normal variants in whole-body PET images. In: Valk PE, Bailey DL, Townsend DW, Maisey MN, eds. Positron Emission Tomography: Basic Science and Clinical Practice. London, U.K.: Springer-Verlag; 2003. p. 495-505.
17. Leisure GP, Vesselle HJ, Faulhaber PF, O'Donnell JK, Adler LP, Miraldi F. Technical improvements in fluorine-18-FDG PET imaging of the abdomen and pelvis. J Nucl Med Technol 1997;25:115-119
18. Vesselle HJ, Miraldi FD. FDG PET of the retroperitoneum: Normal anatomy, variants, pathologic conditions, and strategies to avoid diagnostic pitfalls. Radiographics 1998;18:805-823
19. Harney JV, Wahl RL, Liebert M, Kuhl DE, Hutchins GD, Wedemeyer G, et al. Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer. Animal localization and initial patient positron emission tomography. J Urol 1991;145:279-283
20. Drieskens O, Oyen R, Van Poppel H, Vankan Y, Flamen P, Mortelmans L. FDG-PET for preoperative staging of bladder cancer. Eur J Nucl Med Mol Imaging 2005;32:1412-1417
21. Watanabe N, Kato H, Shimizu M, Noguchi K, Kamisaki Y, Fuse H, et al. A case of renal pelvic tumor visualized by 18F-FDG imaging. Ann Nucl Med 2004;18:161-163
22. Etchebehere EC, Macapinlac HA, Gonen M, Humm K, Yeung HW, Akhurst T, et al. Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of FDG PET. Q J Nucl Med 2002;46:122-130
23. Heicappell R, Müller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Müller-Gärtner H, et al. Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-(18F)-2-deoxy-D-glucose. Eur Urol 1999;36:582-587
24. Anjos DA, Etchebehere EC, Ramos CD, Santos AO, Albertotti C, Camargo EE. FDG-PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder Cancer. J Nucl Med 2007;48:764-770
25. Kamel EM, Jichlinski P, Prior JO, Meuwly JY, Delaloye JF, Vaucher L, et al. Forced diuresis improves the diagnostic accuracy of FDG PET in abdominopelvic malignancies. J Nucl Med 2006;47:1803-1807